Global Patterns of Care for HER2/Neu Overexpressing Breast Cancer

被引：0
|
作者：
Chavarri-Guerra, Y. [1 ]
Liedke, P. [1 ]
Symecko, H. [1 ]
Moy, B. [1 ]
Higgins, M. [1 ]
St Louis, J. [1 ]
Finkelstein, D. [1 ]
Goss, P. [1 ]
机构：
[1] Massachusetts Gen Hosp, Avon Int Breast Canc Program, Boston, MA 02114 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P1-12-26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-12-26
引用
收藏
页数：1
相关论文
共 50 条
  • [11] HER2/neu in the management of invasive breast cancer
    Meric, F
    Hung, MC
    Hortobagyi, GN
    Hunt, KK
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2002, 194 (04) : 488 - 501
  • [12] HER2:: The Neu prognostic marker for breast cancer
    Tsongalis, GJ
    Ricci, A
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2001, 38 (02) : 167 - 182
  • [13] HER2/neu as a predictive factor in breast cancer
    Piccart, M
    Hamilton, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S84 - S84
  • [14] Anti-idiotype antibody vaccine therapy for HER2/Neu overexpressing breast cancer.
    Nahleh, ZA
    Mohanty, K
    Pal, S
    Mallick, P
    Saha, A
    Chatterjee, SK
    Jazieh, A
    Foon, KA
    Bhattacharya-Chatterjee, M
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S197 - S198
  • [15] Cytotoxicity of breast cancer cells overexpressing HER2/neu by 213Bi-Herceptin radioimmunoconjugate
    Zhang, DY
    Li, Y
    Rizvi, SMA
    Qu, CF
    Kearsley, J
    Allen, BJ
    CANCER LETTERS, 2005, 218 (02) : 181 - 190
  • [16] Detection of elevated HER2/neu levels in breast cancer cell lines overexpressing estrogen receptor β
    Lattrich, C.
    Juhasz-Boss, I.
    Ortmann, O.
    Treeck, O.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S242 - S242
  • [17] Is the combination of trastuzumab and vinorelbine an active regimen in metastatic breast cancer patients overexpressing HER2/neu?
    Czerniawska, M
    Jagiello-Gruszfeld, AI
    Zbrzezniak, J
    Wachula, E
    Kazarnowicz, A
    Sikorska, M
    Szablowska-Siwik, S
    Ziomek, M
    Gugala, K
    ANNALS OF ONCOLOGY, 2005, 16 : 277 - 277
  • [18] HER2/neu overexpressing Primary Breast Squamous cell Carcinoma: A case report of an
    Koulia, K.
    Tsavari, A.
    Apostolopoulos, A.
    Sotiropoulou, G.
    Vasilakaki, T.
    Manoloudaki, K.
    Arkoumani, E.
    VIRCHOWS ARCHIV, 2016, 469 : S52 - S52
  • [19] Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells
    Way, TD
    Kao, MC
    Lin, JK
    FEBS LETTERS, 2005, 579 (01): : 145 - 152
  • [20] Dose scheduling and pharmacokinetic (PK) study of trastuzumab in patients (pts) with HER2/neu overexpressing breast cancer?
    Felici, A.
    Di Segni, S.
    Contestabile, M.
    Nuvoli, B.
    Fabi, A.
    Papaldo, P.
    Ferretti, G.
    Sperduti, I.
    Citro, G.
    Cognetti, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345